dactinomycin has been researched along with paclitaxel in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (16.98) | 18.2507 |
| 2000's | 26 (49.06) | 29.6817 |
| 2010's | 15 (28.30) | 24.3611 |
| 2020's | 3 (5.66) | 2.80 |
| Authors | Studies |
|---|---|
| Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
| Chen, CY; Chen, YJ; Hwang, JF; Kuo, YH; Prakash, CV; Shen, YC | 1 |
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Chakraborty, R; Chien, CT; Kuo, YH; Lin, YC; Lo, KL; Pan, YL; Shen, YC; Wang, SS | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Gibbons, S; Kaatz, GW; Zloh, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Luesch, H; Matthew, S; Schupp, PJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hill, BT; Hosking, LK; McClean, S; Whelan, RD | 1 |
| Aizu-Yokota, E; Sato, Y; Susaki, A | 1 |
| Cóias, R; Galego, L; Rodrigues-Pousada, C; Soares, H | 1 |
| Collier, NC; Schlesinger, MJ; Sheetz, MP | 1 |
| Jones, WB; Lewis, JL; Schneider, J; Shapiro, F | 1 |
| Das, KC; White, CW | 1 |
| Blagosklonny, MV; Fojo, T; Iglesias, A; Zhan, Z | 1 |
| Choi, BM; Chung, HT; Kim, TY; Pae, HO; Yoo, JC | 1 |
| Bargellesi, A; Cosulich, E; Fabbi, M; Gangemi, RM; Santamaria, B | 1 |
| Cheng, SC; Luo, D; Xie, Y; Zhou, J | 1 |
| Cantoni, C; Daga, A; Lunardi, C; Millo, R; Oliveri, M; Puccetti, A | 1 |
| Adsay, VN; Glazyrin, AL; Sarkar, FH; Vaitkevicius, VK | 1 |
| Fox, R | 1 |
| Regar, E; Serruys, PW; Sianos, G | 1 |
| Carter, AJ; Hiatt, BL; Ikeno, F; Yeung, AC | 1 |
| Algarra, I; Gaforio, JJ; Jaén, A; Lozano, A; Sánchez-Rovira, P; Serrano, MJ | 1 |
| Büllesfeld, L; Gerckens, U; Grube, E; Müller, R | 1 |
| Bergstralh, DT; Clements, C; MacKeigan, JP; Taxman, DJ; Ting, JP | 1 |
| Kipshidze, N; Leon, MB; Moses, JW | 1 |
| Debatin, KM; Fulda, S | 1 |
| Cheng, SC; Xie, Y; Zhou, J | 1 |
| Bhalla, K; Blagosklonny, MV; Broude, EV; Demidenko, ZN; Halicka, HD; Li, CJ; Vivo, C | 1 |
| Freitas, J; Jansen, HM; Keles, F; Lutter, R; Snoek, M; van den Berg, A; van Marle, J | 1 |
| Amikura, T; Aoki, Y; Banzai, C; Nishikawa, N; Sekine, M; Suzuki, M; Tanaka, K; Yokoo, T | 1 |
| Eksborg, S; Flaberg, E; Kis, LL; Markasz, L; Olah, E; Otvos, R; Skribek, H; Stuber, G; Szekely, L | 1 |
| Bae, SN; Jung, SG; Kim, CJ; Kim, SJ; Lee, C; Na, YJ | 1 |
| Abe, T; Goto, J; Hishinuma, T; Kobayashi, M; Mano, N; Okada, M; Takeuchi, T; Unno, M; Yamaguchi, H | 1 |
| Jefferson, B; Lobert, S; Morris, K | 1 |
| Breitenbuecher, F; Guyot, M; Hoffarth, S; Höhn, Y; Meiler, J; Schuler, M; Wesarg, E | 1 |
| Chen, J; Jin, MS; Oldham, ML; Zhang, Q | 1 |
| Akutsu, H; Kimura, H; Lee, SW; Masui, S; Nagashima, Y; Nishi, M; Perrem, K; Quinn, G; Ryo, A; Sakai, Y; Umezawa, A; Yamamoto, N | 1 |
| Chong, Y; Choo, H; Kim, MK | 1 |
| Ashton, E; Hoffman, J; Shafer, A; Szutowska, M | 1 |
| Hatem, E; He, T; Huang, ME; Lei, M; Vernis, L | 1 |
| Msaouel, P; Tu, SM; Zhang, M | 1 |
| Almeida, A; Bartosch, C; Cruz Pires, M; Peixinho, C | 1 |
| Alsherbiny, MA; Bhuyan, DJ; Chang, D; Li, CG; Low, MN | 1 |
| Gillett, S; Hapuarachi, B; Ireson, J; Romanowski, C; Singh, K; Tidy, JA; Winter, MC | 1 |
4 review(s) available for dactinomycin and paclitaxel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Stent development and local drug delivery.
Topics: Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Antineoplastic Agents; Biodegradation, Environmental; Coronary Restenosis; Dactinomycin; Drug Delivery Systems; Equipment Design; Humans; Myocardial Ischemia; Paclitaxel; Protein Synthesis Inhibitors; Sirolimus; Stents | 2001 |
Perspectives of drug-eluting stents: the next revolution.
Topics: Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents; Coronary Restenosis; Dactinomycin; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2002 |
Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Paclitaxel; Placenta; Pregnancy; Quality of Life; Retrospective Studies; Vincristine | 2023 |
49 other study(ies) available for dactinomycin and paclitaxel
| Article | Year |
|---|---|
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
Taxane diterpenoids from the stem bark of Taxus mairei.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Paclitaxel; Plant Stems; Plants, Medicinal; Structure-Activity Relationship; Taxoids; Tumor Cells, Cultured | 2001 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
New taxane diterpenoids from the leaves and twigs of Taxus sumatrana.
Topics: Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Diterpenes; Drug Screening Assays, Antitumor; Humans; KB Cells; Molecular Structure; Plant Leaves; Plant Stems; Plants, Medicinal; Taxoids; Taxus; Tumor Cells, Cultured | 2002 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Cell Membrane; Drug Resistance, Microbial; Drug Resistance, Multiple; Ligands; Models, Molecular | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Apratoxin E, a cytotoxic peptolide from a guamanian collection of the marine cyanobacterium Lyngbya bouillonii.
Topics: Antineoplastic Agents; Cyanobacteria; Cytotoxins; Depsipeptides; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Female; Guam; Humans; Lyngbya Toxins; Marine Toxins; Molecular Structure; Nuclear Proteins | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Expression of drug resistance in Chinese hamster ovary (CHO) cells following X-ray pre-treatment in vitro.
Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Survival; CHO Cells; Cricetinae; Dactinomycin; Drug Resistance; Lactones; Macrolides; Paclitaxel; Ricin; Vinblastine; Vincristine; Vinorelbine; X-Rays | 1991 |
Natural estrogens induce modulation of microtubules in Chinese hamster V79 cells in culture.
Topics: Animals; Cell Division; Cells, Cultured; Cricetinae; Cricetulus; Cycloheximide; Cytoplasm; Dactinomycin; Estradiol; Estrogens; Microtubules; Paclitaxel | 1995 |
The mechanisms of tubulin messenger regulation during Tetrahymena pyriformis reciliation.
Topics: Animals; Base Sequence; Blotting, Northern; Cilia; Dactinomycin; DNA, Protozoan; Gene Expression Regulation; Heat-Shock Proteins; Molecular Sequence Data; Paclitaxel; Pactamycin; RNA, Messenger; RNA, Protozoan; Tetrahymena pyriformis; Transcription, Genetic; Tubulin; Ubiquitins | 1993 |
Concomitant changes in mitochondria and intermediate filaments during heat shock and recovery of chicken embryo fibroblasts.
Topics: Animals; Chick Embryo; Dactinomycin; Endoplasmic Reticulum; Fibroblasts; Histocytochemistry; Hot Temperature; Intermediate Filaments; Mitochondria; Paclitaxel; Shock | 1993 |
Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Frontal Lobe; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms; Vincristine | 1996 |
Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C.
Topics: Adenocarcinoma; Antineoplastic Agents; Binding, Competitive; Cell Nucleus; Cycloheximide; Dactinomycin; Daunorubicin; Dexamethasone; Doxorubicin; Enzyme Inhibitors; Humans; Kinetics; Lung Neoplasms; NF-kappa B; Oligodeoxyribonucleotides; Paclitaxel; Protein Kinase C; Transcription Factors; Tumor Cells, Cultured; Vincristine | 1997 |
Like p53, the proliferation-associated protein p120 accumulates in human cancer cells following exposure to anticancer drugs.
Topics: Antineoplastic Agents; Base Sequence; Cell Division; Dactinomycin; Daunorubicin; DNA Damage; DNA Primers; Doxorubicin; Humans; Microtubules; Mitomycin; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Polymerase Chain Reaction; Transcription, Genetic; tRNA Methyltransferases; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine | 1998 |
Protective effects of glucocorticoids on taxol-induced cytotoxicity in human leukemia HL-60 cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Colchicine; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Glucocorticoids; HL-60 Cells; Humans; Paclitaxel | 1999 |
Late apoptotic effects of taxanes on K562 erythroleukemia cells: apoptosis is delayed upstream of caspase-3 activation.
Topics: Apoptosis; Caspase 3; Caspases; Cell Survival; Dactinomycin; Docetaxel; Dose-Response Relationship, Drug; Enzyme Activation; HL-60 Cells; Humans; K562 Cells; Kinetics; Paclitaxel; Taxoids; Time Factors | 2000 |
Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Survival; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Mitomycin; Paclitaxel; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Time Factors; Tubulin; Tumor Cells, Cultured; Vinblastine; Vincristine | 2001 |
DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.
Topics: Apoptosis; Cell Nucleus; Cell Survival; Cycloheximide; Dactinomycin; Deoxyribonuclease I; DNA; DNA Fragmentation; Etoposide; fas Receptor; Gene Targeting; Humans; Jurkat Cells; Kinetics; Nucleosomes; Paclitaxel; Transfection; Tumor Cells, Cultured | 2001 |
CD95-related apoptotic machinery is functional in pancreatic cancer cells.
Topics: Adenocarcinoma; Apoptosis; Bleomycin; Dactinomycin; Enzyme Activation; fas Receptor; Flow Cytometry; Genes, p53; Humans; Interferon-gamma; Kinetics; Mutation; Paclitaxel; Pancreatic Neoplasms; Peptide Hydrolases; Signal Transduction; Tumor Cells, Cultured | 2001 |
American Heart Association 2001 scientific sessions: late-breaking science-drug-eluting stents.
Topics: Clinical Trials as Topic; Coronary Restenosis; Dactinomycin; Humans; Paclitaxel; Sirolimus; Stents | 2001 |
Drug-eluting stents for the prevention of restenosis: in quest for the Holy Grail.
Topics: Animals; Cell Division; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Restenosis; Dactinomycin; Depression, Chemical; Humans; Infusion Pumps, Implantable; Muscle, Smooth, Vascular; Paclitaxel; Sirolimus; Stents | 2002 |
Evaluation of a gemcitabine-doxorubicin-paclitaxel combination schedule through flow cytometry assessment of apoptosis extent induced in human breast cancer cell lines.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Division; Cell Survival; Clinical Trials as Topic; Dactinomycin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Flow Cytometry; Gemcitabine; Humans; Paclitaxel; Time Factors; Tumor Cells, Cultured | 2002 |
Drug eluting stents: initial experiences.
Topics: Angiogenesis Inhibitors; Angioplasty, Balloon, Coronary; Animals; Coated Materials, Biocompatible; Coronary Restenosis; Dactinomycin; Drug Delivery Systems; Follow-Up Studies; Humans; Immunosuppressive Agents; Multicenter Studies as Topic; Paclitaxel; Pilot Projects; Protein Synthesis Inhibitors; Randomized Controlled Trials as Topic; Safety; Sirolimus; Stents; Swine; Tacrolimus; Time Factors | 2002 |
Transcriptional profiling of targets for combination therapy of lung carcinoma with paclitaxel and mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Butadienes; Chemokine CXCL1; Chemokines; Chemokines, CXC; Chemotactic Factors; Dactinomycin; Enzyme Inhibitors; Female; Gene Expression Profiling; Humans; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Melanoma; Mitogen-Activated Protein Kinase Kinases; Nitriles; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Paclitaxel | 2003 |
Sensitization for anticancer drug-induced apoptosis by betulinic Acid.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Caspases; Cells, Cultured; Cisplatin; Complement Membrane Attack Complex; Complement System Proteins; Cytochromes c; Dactinomycin; Doxorubicin; Drug Synergism; Enzyme Activation; Etoposide; Fibroblasts; Glycoproteins; Humans; Membrane Potentials; Mitochondria; Mutation; Neoplasms; Paclitaxel; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-bcl-2; Triterpenes; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2005 |
P-glycoprotein expression induced by glucose depletion enhanced the chemosensitivity in human hepatocellular carcinoma cell-lines.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Culture Media; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Glucose; Humans; Inhibitory Concentration 50; Paclitaxel; Vinblastine; Vincristine | 2005 |
Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection.
Topics: Amino Acid Chloromethyl Ketones; Antibiotics, Antineoplastic; Apoptosis; Benzoquinones; Caspase 9; Caspase Inhibitors; Cell Cycle; Cell Line, Tumor; Cytoprotection; Dactinomycin; Doxorubicin; Enzyme Activation; Flavonoids; HSP70 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Paclitaxel; Piperidines; Protein Biosynthesis; RNA, Small Interfering; Transcriptional Activation | 2006 |
Cytoskeletal architecture differentially controls post-transcriptional processing of IL-6 and IL-8 mRNA in airway epithelial-like cells.
Topics: CCAAT-Enhancer-Binding Protein-beta; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Cytochalasin D; Cytoskeleton; Dactinomycin; Depsipeptides; Epithelial Cells; Humans; Interleukin-12; Interleukin-6; Lung; NF-kappa B; Paclitaxel; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vinblastine | 2006 |
Metastatic choriocarcinoma successfully treated with paclitaxel and carboplatin after interstitial lung disease induced by EMA-CO.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Lung Neoplasms; Methotrexate; Paclitaxel; Uterine Neoplasms; Vincristine | 2006 |
Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Dactinomycin; Hodgkin Disease; Humans; Paclitaxel | 2007 |
Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Korea; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Salvage Therapy; Severity of Illness Index; Uterine Neoplasms | 2007 |
Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes.
Topics: Antineoplastic Agents; Camptothecin; Chenodeoxycholic Acid; Dactinomycin; Docetaxel; Fluorescent Dyes; Humans; Irinotecan; Kinetics; Lysine; Mitoxantrone; Organic Anion Transporters, Sodium-Independent; Paclitaxel; Signal Processing, Computer-Assisted; Solute Carrier Organic Anion Transporter Family Member 1B3; Spectrometry, Fluorescence; Taxoids; Transfection | 2008 |
Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Dactinomycin; Female; Gene Expression Regulation, Neoplastic; Humans; Microarray Analysis; MicroRNAs; Paclitaxel; Protein Isoforms; Tubulin; Tubulin Modulators | 2011 |
Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer.
Topics: Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; bcl-X Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Antagonism; Drug Synergism; Etoposide; Humans; Immunoblotting; Lung Neoplasms; Paclitaxel; Protein Kinase C; Signal Transduction; Staurosporine; Time Factors | 2012 |
Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans.
Topics: Adenosine Triphosphate; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Caenorhabditis elegans; Crystallography, X-Ray; Dactinomycin; Humans; Hydrolysis; Lipid Bilayers; Models, Biological; Models, Molecular; Paclitaxel; Protein Structure, Tertiary; Structural Homology, Protein; Structure-Activity Relationship | 2012 |
Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.
Topics: Animals; Breast Neoplasms; CD24 Antigen; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cellular Reprogramming; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Dactinomycin; Drug Resistance, Neoplasm; Epithelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Induced Pluripotent Stem Cells; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mammary Glands, Human; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Naphthoquinones; Neoplastic Stem Cells; Octamer Transcription Factor-3; Paclitaxel; Proto-Oncogene Proteins c-myc; Pyrans; SOXB1 Transcription Factors; Spheroids, Cellular | 2014 |
Water-soluble and cleavable quercetin-amino acid conjugates as safe modulators for P-glycoprotein-based multidrug resistance.
Topics: Alanine; Amino Acids; Antineoplastic Agents; Antioxidants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Tumor; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Glutamic Acid; Humans; Microscopy, Confocal; Models, Chemical; Molecular Structure; Paclitaxel; Quercetin; Verapamil; Vinblastine | 2014 |
Attempted conservative management of a placental site trophoblastic tumor: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lymph Node Excision; Methotrexate; Paclitaxel; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2014 |
PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug.
Topics: Antineoplastic Agents; Dactinomycin; Daunorubicin; Doxorubicin; Fluorouracil; Gene Knockdown Techniques; HeLa Cells; Homeodomain Proteins; Humans; Neoplasms; Paclitaxel; Reactive Oxygen Species; Vinblastine; Vitamin K 3 | 2015 |
Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Transitional Cell; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Deoxycytidine; Doxorubicin; Etoposide; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pelvic Neoplasms; Remission Induction; Ureteral Neoplasms | 2017 |
Placental site trophoblastic tumour: five challenges of patient clinical management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Consolidation Chemotherapy; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Lung Neoplasms; Lymph Node Excision; Methotrexate; Paclitaxel; Pregnancy; Puerperal Disorders; Salpingectomy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms | 2021 |
Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cannabidiol; Cell Line, Tumor; Cell Survival; Dactinomycin; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Irinotecan; MCF-7 Cells; Paclitaxel; Proteome; Proteomics; Vinorelbine | 2021 |